CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Enrico Sangiovanni

OPENALEX: A5049344232↗ORCID: 0000-0003-2811-8628↗

Affiliations

Organizations

University of Milanauthorship · IT University of Opoleauthorship · PL

Public evidence

3 connected articles

Cannabizetol, a Novel Cannabinoid: Chemical Synthesis, Anti-inflammatory Activity and Extraction from <i>Cannabis sativa</i> L.2025 · Europe PMC Beyond Cannabidiol: The Contribution of <i>Cannabis sativa</i> Phytocomplex to Skin Anti-Inflammatory Activity in Human Skin Keratinocytes.2025 · Europe PMC Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network.2022 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Enrico Sangiovanni - Medical Cannabis Research Engine